SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Daseke, Inc. (DSKE) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DSKE
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.24
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.39
Book Value / Share$0.00
Revenue / Share$34.25
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$1.94 |
$542.71M |
$272K |
0.1% |
| 2015 |
$-0.07 |
$678.85M |
$3.26M |
0.5% |
| 2016 |
$-0.45 |
$651.8M |
$-9.48M |
-1.5% |
| 2017 |
$0.56 |
$846.3M |
$27M |
3.2% |
| 2018 |
$-0.08 |
$1.61B |
$-5.19M |
-0.3% |
| 2019 |
$-4.78 |
$1.74B |
$-307.4M |
-17.7% |
| 2020 |
$0.10 |
$1.45B |
$6.2M |
0.4% |
| 2021 |
$0.78 |
$1.56B |
$56M |
3.6% |
| 2022 |
$0.70 |
$1.77B |
$50.2M |
2.8% |
| 2023 |
$-0.39 |
$1.57B |
$-17.7M |
-1.1% |
